Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein

Virus Research

Volumn 160, Issue 1-2, 2011, Pages 74-81

  Ripoli, Maria ^a   Barbano, Raffaela ^a   Balsamo, Teresa ^a   Piccoli, Claudia ^b   Brunetti, Virgilio ^c   Coco, Michelina ^a   Mazzoccoli, Gianluigi ^a   Vinciguerra, Manlio ^d   Pazienza, Valerio ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

Author keywords

CDH1; DNA methylation; HCC; HCV core

Indexed keywords

APC PROTEIN; BETA CATENIN; CORE PROTEIN; GLUTATHIONE TRANSFERASE P1; SIRTUIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UVOMORULIN;

ARTICLE; CONTROLLED STUDY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION;

CADHERINS; CELL LINE; DNA METHYLATION; GENE EXPRESSION; HEPACIVIRUS; HEPATOCYTES; HUMANS; PROMOTER REGIONS, GENETIC; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 80052145029     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.05.014     Document Type: Article

References (45)

1. Abid K., Pazienza V., de Gottardi A., Rubbia-Brandt L., Conne B., Pugnale P., Rossi C., Mangia A., Negro F. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J. Hepatol. 2005, 42:744-751.
2. Arora P., Kim E.O., Jung J.K., Jang K.L. Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b. Cancer Lett. 2008, 261(March (2)):244-252.
3. Beavon I.R. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur. J. Cancer 2000, 36:1607-1620.
4. Benhenda S., Cougot D., Neuveut C., Buendia M.A. Liver cell transformation in chronic HBV infection. Viruses 2009, 1(3):630-646.
5. Brooks C.L., Gu W. How does SIRT1 affect metabolism, senescence and cancer?. Nat. Rev. Cancer 2009, 9(February (2)):123-128. (Epub 2008 December 29).
6. Cadigan K.M., Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997, 11(December (24)):3286-3305.
7. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., Howitz K.T., Gorospe M., de Cabo R., Sinclair D.A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305(July (5682)):390-392.
8. Csepregi A., Röcken C., Hoffmann J., Gu P., Saliger S., Müller O., Schneider-Stock R., Kutzner N., Roessner A., Malfertheiner P., Ebert M.P.A. APC promoter methylation and protein expression in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2008, 134(May (5)):579-589.
9. Dejeux E., Audard V., Cavard C., Gut I.G., Terris B., Tost J. Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample pools. J. Mol. Diagn. 2007, Vol. 9(4).
10. Diehl J.A., Cheng M., Roussel, Sherr C. Glycogen synthase kinase-3b regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998, 12:3499-3511.
11. Domnez G., Guarente L. Aging and disease: connections to sirtuins. Aging Cell 2010, 9(March (2)):285-290.
12. El-Serag H.B. Hepatocellular carcinoma and hepatitis C in the United States A. Hepatology 2002, 36(5 Suppl. 1):S74-S83.
13. Franco E.L., Villa L.L., Ruiz A., Costa M.C. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J. Infect. Dis. 1995, 172:756-763.
14. Hasan F., Jeffers L.J., De Medina M.K., Reddy R., Parker T., Schiff E.R.F.A.C.P., Houghton M., Choo Q., Kuo G. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990, 12:589-591.
15. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 1996, 6:986-994.
16. Huibregtse J.M., Beaudenon S.L. Mechanism of HPV E6 proteins in cellular transformation. Semin. Cancer Biol. 1996, 7:317-326.
17. Jeronimo C., Usadel H., Henrique R., et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J. Natl. Cancer Inst. 2001, 93:1747-1752.
18. Kondo Y., Kanai Y., Sakamoto M., Mizokami M., Ueda R., Hirohashi S. Genetic instability and aberrantDNAmethylation in chronic hepatitis and cirrhosis: a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA ypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 2000, 32:970-979.
19. Lee S., Lee H.J., Kim J.H., Lee H.S., Jang J.J., Kang G.H. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am. J. Pathol. 2003, 163:1371-1378.
20. Levrero M. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 2006, 25:3834-3847.
21. Liu T., Liu P.T., Marshall G.M. The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res. 2009.
22. Lo Y.M., Wong I.H., Zhang J., Tein M.S., Ng M.H., Hjelm N.M. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res. 1999, 59:3899-3903.
23. Mareel G., Berx F., Van Roy, Bracke M. Cadherin/catenin complex: a target for antiinvasive therapy?. J. Cell. Biochem. 1996, 61:524-530.
24. McCormick C.J., Rowlands D.J., Harris M. Efficient delivery and regulable expression of hepatitis C virus full-length and minigenome constructs in hepatocyte-derived cell lines using baculovirus vectors. J. Gen. Virol. 2002, 83:383-394.
25. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 1998, 4(September (9)):1065-1067.
26. O'Hagan H.M., Mohammad H.P., Baylin S.B. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet. 2008, 4(August (8)). e1000155.
27. Park C.Y., Choi S.H., Kang S.M., Kang J.I., Ahn B.Y., Kim H., Jung G., Choi K.Y., Hwang S.B. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J. Hepatol. 2009, 51(November (5)):853-864.
28. Parrella P., la Torre A., Copetti M., Valori V.M., Barbano R., Notarangelo A., et al. High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas. J. Biomed. Biotechnol. 2009, 20.
29. Pazienza V., Clement S., Pugnale P., Conzelmann S., Pascarella S., Mangia A., Negro F. Gene expression profile of Huh-7 cells expressing hepatitis C virus genotype 1b or 3a core proteins. Liver Int. 2009, 29(May (5)):661-669.
30. Pruitt K., Zinn R.L., Ohm J.E., McGarvey K.M., Kang S.H., Watkins D.N., Herman J.G., Baylin S.B. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2006, 2(March (3)):e40.
31. Raimondi S., Bruno S., Mondelli M.U., Maisonneuve P. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J. Hepatol. 2009, 50(June (6)):1142-1154.
32. Ropero S., Esteller M. The role of histone deacetylases (HDACs) in human cancer. Mol. Oncol. 2001, 7(March (1)):17-25.
33. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 1990, 87(September (17)):6547-6549.
34. Schaller T., Appel N., Koutsoudakis G., Kallis S., Lohmann V., Pietschmann T., Bartenschlager R. Analysis of Hepatitis C virus suoperinfection exclusion by using novel fluorochrome gene-tagged viral genome. J. Virol. 2007, 81(May (9)):4591-4603.
35. Simonetti R.G., Cammà C., Fiorello F., Cottone M., Rapicetta M., Marino L., Fiorentino G., Craxì A., Ciccaglione A., Giuseppetti R., et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann. Intern. Med. 1992, 116(January (2)):97-102.
36. Street A., Macdonald A., McCormick C., Harris M. Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. J. Virol. 2005, 79(April (8)):5006-5016.
37. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 1993, 5:806-811.
38. Tellinghuisen T.L., Rice C.M. Interaction between hepatitis C virus proteins and host cell factors. Curr. Opin. Microbiol. 2002, 5(August (4)):419-427.
39. Thorgeirsson S.S., Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002, 31(August (4)):339-346.
40. Tischoff I., Tannapfel A. DNA methylation in hepatocellular carcinoma. World J. Gastroenterol. 2008, 14(March (11)):1741-1748.
41. Wang C., Lihong C., Xinghua H., Zhenyu L., Neha K., Yihong M., Shino N., Toren F., Wei G., Douglas Cress W., Jiandong C. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat. Cell Biol. 2006, 8:1025-1031.
42. Yang B., Guo M., Herman J.G., Clark D.P. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am. J. Pathol. 2003, 163:1101-1107.
43. Yoshida T., Hanada T., Tokuhisa T., Kosai K., Sata M., Kohara M., Yoshimura A. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J. Exp. Med. 2002, 196(September (5)):641-653.
44. Yost C., Torres M., Miller J.R., Huang E., Kimelman D., Moon R.T. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 1996, 10:1443-1454.
45. Yu J., Ni M., Xu J., Zhang H., Gao B., Gu J., et al. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2002, 2:29.